Free Trial
→ Critical 'Buy Now' Alert on My Favorite Stock! (From Behind the Markets) (Ad)

DarioHealth Q3 2023 Earnings Report

DarioHealth logo
$0.63 -0.01 (-0.95%)
As of 09:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Earnings HistoryForecast

DarioHealth EPS Results

Actual EPS
-$0.49
Consensus EPS
-$0.50
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

DarioHealth Revenue Results

Actual Revenue
$3.52 million
Expected Revenue
$4.13 million
Beat/Miss
Missed by -$610.00 thousand
YoY Revenue Growth
N/A

DarioHealth Announcement Details

Quarter
Q3 2023
Date
11/2/2023
Time
N/A

Conference Call Resources

DarioHealth Earnings Headlines

DarioHealth stock hits 52-week low at $0.63 amid market challenges
January 30 at 11:57 AM | msn.com
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation
January 30 at 8:45 AM | businesswire.com
Unlock the Secret to Microsoft's Yearly Gains
What would you do if you knew that you could have placed a trade on Microsoft every year on October 13th … And had the chance to pocket an impressive gain in a matter of days… And this didn’t work just once… Not twice… But it worked for an entire decade… According to market veteran Jack Carter’s research, the recurring phenomenon generated winner after winner for 10 straight years! All you had to do is wait for October 13th to roll around on the calendar… Then place a quick trade… Of course, we can’t promise profits or prevent losses… But you can get 10 FREE trade ideas from Jack, just like that one on Microsoft.
January 31, 2025 | Jack Carter Trading (Ad)
TD Cowen cuts DarioHealth stock rating amid growth concerns
January 29 at 8:49 AM | msn.com
DarioHealth Corp. Secures $25.6 Million Private Placement to Support Strategic Operational Objectives
January 25, 2025 | americanbankingnews.com
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025
January 21, 2025 | prnewswire.com
See More DarioHealth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DarioHealth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DarioHealth and other key companies, straight to your email.

About DarioHealth

DarioHealth (NASDAQ:DRIO) operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

View DarioHealth Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles